Loading company…
Riskpilot
← Back to search
Sign in
Get full access
OM Narkos AB
AB
Active
Org 5568717598
Prins Augusts Gata 14
General medical practice activities · NACE 8621
Est. 2011
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 394K
-60% vs 2024
EBITDA margin
19.9%
+3% vs 2024
Equity ratio
54.1%
Financial strength
Net profit 2025
SEK 62K
-48% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 394K
-60%
EBITDA
SEK 78K
+3%
Net profit
SEK 62K
-48%
Total assets
SEK 222K
-66%
Equity
SEK 120K
-29%
Employees
1
—
Company information
Legal name
OM Narkos AB
Org number
5568717598
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 november 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av Anad, Max Raid
Company purpose
Aktiebolaget ska bedriva anestesi- och intensivvård verksamhet och därmed förenlig verksamhet.
Contact
Address
Prins Augusts Gata 14
Phone
+46462112662
Email
anad.raid@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Malmö
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
1M
2023
1M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
1 055
932
977
394
Staff expenses
—
−688
−872
−878
−275
EBITDA
−6
308
13
76
78
Depreciation & amort.
−0
—
—
—
—
EBIT
−6
308
13
76
78
Net financials
—
0
3
−1
0
Profit before tax
−6
234
16
150
78
Tax
−0
−50
−4
−33
−17
Net profit
−6
184
12
118
62
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
51
739
636
651
222
Equity
49
233
63
168
120
Long-term debt
0
—
—
—
—
Short-term debt
2
431
498
483
102
Total debt
2
431
498
483
102
Financial ratios
5-year trend
EBITDA margin
19.9%
This company
15.8%
Market median
+26% vs market
2021
2025
Equity ratio
54.1%
This company
38.2%
Market median
+42% vs market
2021
2025
Return on equity
51.4%
This company
18.4%
Market median
+179% vs market
2021
2025
Net profit margin
15.7%
This company
8.1%
Market median
+94% vs market
2021
2025
Asset turnover
1.77×
This company
1.12×
Market median
+58% vs market
2021
2025
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MR
Max Raid Anad
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
SA
Suzanne Anad
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of OM Narkos AB also hold positions in
0
other companies.
Person
Role here
Other companies
Max Raid Anad
Chief Executive Officer
0 companies
Suzanne Anad
Deputy Board Member
0 companies